Skip to main content

Hyoscyamine News

FDA Medwatch Alert: Hyoscyamine sulfate 0.125mg by Virtus Pharmaceuticals: Recall - Superpotent and Subpotent Test Results

ISSUE: Virtus Pharmaceuticals Opco II, LLC (Virtus) is voluntarily recalling seven batches of Hyoscyamine sulfate (0.125mg) to the consumer level which include the tablet, sublingual, and orally...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Diverticulitis, Crohn's Disease, Anesthesia, Irritable Bowel Syndrome, Rhinitis, Urinary Incontinence

Hyoscyamine patient information at Drugs.com